Skip to Content

Pharmaceuticals, Volume 3, Issue 11

2010 November - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Review
  • Open Access
9 Citations
14,669 Views
16 Pages

9 November 2010

Patients with hypertension often manifest a dysregulated renin-angiotensin-aldosterone system (RAAS). Most of the available treatment approaches for hypertension are targeted towards the RAAS including direct renin inhibition, ACE inhibition, angiote...

  • Review
  • Open Access
11 Citations
8,601 Views
17 Pages

3 November 2010

GABAA receptors mediate the majority of the fast inhibition in the mature brain and play an important role in the pathogenesis of many neurological and psychiatric disorders. The αβδ GABAA receptor localizes extra- or perisynaptically and mediates GA...

  • Review
  • Open Access
31 Citations
16,080 Views
26 Pages

Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties

  • Michèle Seil,
  • Carole Nagant,
  • Jean-Paul Dehaye,
  • Michel Vandenbranden and
  • Marc Ferdinand Lensink

1 November 2010

Cationic antimicrobial peptides are major components of innate immunity and help control the initial steps of the infectious process. They are expressed not only by immunocytes, but also by epithelial cells. They share an amphipathic secondary struct...

  • Article
  • Open Access
2 Citations
8,711 Views
18 Pages

Multiple Routes to Oestrogen Antagonism

  • Hilary R. Glover,
  • Stewart Barker,
  • Sylvanie D. M. Malouitre,
  • John R. Puddefoot and
  • Gavin P. Vinson

29 October 2010

Several lines of evidence attest to the existence of alternative ligand binding sites on the oestrogen receptor (ER), including non-competitive inhibition by trilostane or tamoxifen. It is possible that the inhibitory action of conventional oestrogen...

  • Review
  • Open Access
3 Citations
11,745 Views
16 Pages

28 October 2010

Since the first endocannabinoid anandamide was identified in 1992, extensive research has been conducted to characterize the elements of the tightly controlled endocannabinoid signaling system. While it was established that the activity of endocannab...

  • Review
  • Open Access
23 Citations
14,273 Views
46 Pages

Nanomedicine Faces Barriers

  • Paul Debbage and
  • Gudrun C. Thurner

28 October 2010

Targeted nanoparticles have the potential to improve drug delivery efficiencies by more than two orders of magnitude, from the ~ 0.1% which is common today. Most pharmacologically agents on the market today are small drug molecules, which diffuse acr...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247